A retrospective chart review of the clinical effects of atypical antipsychotic drugs on glycemic control in institutionalized patients with schizophrenia and comorbid diabetes mellitus

Effective lifestyle interventions to improve type II diabetes self-management for those with schizophrenia or schizoaffective disorder: a systematic review

“…While it has been reported that people with schizophrenia may be genetically predisposed to type II diabetes, several other risk factors could contribute to the development of type II diabetes among people with schizophrenia [7]. Some antipsychotic medications such as olanzapine and clozapine, can cause side effects that promote the onset of type II diabetes [8-10]. These side effects include weight gain, dyslipidemia, hypertension, cardiovascular disease and decreased glucose tolerance [4,6,11].…”

Comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: Revisión sistemática y metaanálisis

“…En la Tabla 1 se presentan los 19 artículos excluídos y la razón de su exclusión [11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29] . En algunos casos en lugar de la diabetes mellitus 2 se consideraron como desenlaces síndrome metabó-lico o intolerancia a los hidratos de carbono, en otros no hubo comparador o se compararon antipsicóticos atípicos entre sí.…”

The 3-Year Clinical and Functional Course of Schizophrenia Among Individuals With and Without Diabetes at Study Entry

“…Studies have shown that individuals with serious mental illness can reduce symptoms of, and risk factors for, diabetes through diet, exercise, behavioral intervention, and pharmacotherapy. [38][39][40][41][42] …”